JAK1

Papers on JAK1

51 papers2 new in 30 days

Monday, October 26

Journal of Translational Medicine

Ruxolitinib reduces retinal blood vessel leakage in rats

In Brown-Norway rats with laser-induced eye damage, the drug reduced abnormal blood vessel area and accelerated the recovery of retinal function.In Brown-Norway rats with laser-induced eye damage, the drug reduced abnormal blood vessel area and accelerated the recovery of retinal function.

The SASP is associated with JAK1/2-STAT3 signaling in senescent ARPE-19 cells.
Rat studyEye
ESC Congress 2026 Abstract

Protein loss made irregular rhythms harder to trigger in mice

Aging mice lacking the protein in heart muscle cells had reduced structural changes in the heart’s upper chambers and lower susceptibility to an experimentally triggered…Aging mice lacking the protein in heart muscle cells had reduced structural changes in the heart’s upper chambers and lower susceptibility to an experimentally triggered irregular heartbeat.

Atrial heart tissue above two mice contrasts extensive scarring and crowded immune cells with more intact fibers and fewer immune cells.
Mouse studyMechanisms

Tuesday, October 6

Biomedicine & Pharmacotherapy

Sunitinib selectively killed senescent cells in the lab

A drug screen in human connective-tissue cells linked the selective killing effect to a protein that receives growth signals.A drug screen in human connective-tissue cells linked the selective killing effect to a protein that receives growth signals.

Figure from Biomedicine & Pharmacotherapy
Experiments in human cellsInterventions

Wednesday, September 30

Friday, September 11

Tuesday, September 1

Wednesday, August 12

Thursday, June 18

Tuesday, June 16

Friday, June 12

International Journal of Molecular Sciences

Drug lowered immune signals but had mixed bone effects in mice

A six-week experiment in 57 female mice modeling accelerated aging found reduced inflammatory signals but no consistent improvement in bone measurements with baricitinib.A six-week experiment in 57 female mice modeling accelerated aging found reduced inflammatory signals but no consistent improvement in bone measurements with baricitinib.

Mouse study · 57 miceBones and joints

Thursday, June 4

Research Square

Delayed drug delivery improved bone repair in aged mice

In an experiment with six aged female mice per group, grafts that delayed ruxolitinib release produced more new bone after nine weeks.In an experiment with six aged female mice per group, grafts that delayed ruxolitinib release produced more new bone after nine weeks.

Preprint: mouse studyBones and joints

Wednesday, May 27

Saturday, May 9

Friday, May 1

Friday, April 3

Monday, March 2

Friday, February 27

Wednesday, January 21

Friday, January 16

Monday, December 22

Wednesday, November 26

Wednesday, October 22

Saturday, August 16

Tuesday, July 29

Monday, July 14

Friday, June 13

Wednesday, May 28

Tuesday, April 29

Friday, March 7

Sunday, February 23